Mitchell C. Posner, MD
Thomas D. Jones Professor of Surgery
Chief, Section of General Surgery
Physician-in-Chief, Comprehensive Cancer Center
Learn More & Contact
Kevin Roggin, MD
Robotic Total Gastrectomy for Patients with CDH1 Mutation
Having your stomach removed by a robot seems like something out of a science fiction movie. However, for patients with the CDH1 gene mutation, the procedure—called a total gastrectomy—can save their lives.
At the University of Chicago Medicine’s multidisciplinary CDH1 clinic, Kevin Roggin, MD, Professor of Surgery, works with radiologists, breast oncologists, genetic risk counselors, nutritionists and psychiatrists to treat patients with CDH1 mutations. In men, having the mutation means living with a 70 percent chance of stomach cancer; in women, it is a 53 percent chance, with an additional increased risk of lobular breast cancer.
An open and closed case
Identifying the mutation early is crucial to patient success. The version of stomach cancer caused by a CDH1 mutation does not form a mass, but instead creates multiple tiny nodules under the surface of the stomach, which are not visible on endoscopy. Therefore, stomach cancer is often detected only after it has progressed to an aggressive, late stage. Identifying patients early involves screening for a familial history of stomach cancer and then working with genetic risk counselors to navigate the ethical implications of genetic testing.
Ultimately, patients may opt to go through with a total gastrectomy, which is the only operation associated with eradicating the risk of this type of cancer. Dr. Roggin is one of few surgeons in the Midwest performing robotic total gastrectomy for CDH1 gene mutation carriers. In fact, he has performed over 15 such procedures for these patients over the past two years with excellent results. All patients had complete curative resections with an average length of stay of six days in the hospital and minimal intraoperative blood loss.
“We can do the procedure safely, and people are in the hospital for a shorter period of time. Nothing is compromised from the standpoint of oncological treatment,” explained Dr. Roggin. Typically, total gastrectomies are performed via an open technique, which can lead to more blood loss, more exposure to bacteria, longer recovery periods, more time in the hospital for the patient and more pain. A robotic technique allows patients to return to their normal lives more quickly, with fewer adverse effects and the same outcomes.
Kevin Roggin, MD
Kevin Roggin, MD
Professor of Surgery
While both robotic and laparoscopic techniques utilize small incisions and long instruments, the two are not the same. In conventional laparoscopic surgery, the procedure is visualized on a television screen. Robotic surgery visualization, however, involves 3D rendering and 10 times magnification. “It’s like the difference between a UHF television and a high-definition LCD screen,” said Dr. Roggin.
At the bedside, Dr. Roggin places all the instruments; then he scrubs and sits in a console eight feet away from the patient, using hand controls and foot pedals to perform the operation. While most current laparoscopic instruments may allow only 4 degrees of freedom, robotic instruments offer 6 to 7 degrees, providing functionality similar to that of the human hand. They also enable tiny wrist movements that facilitate working in tight spaces and allow dissection of tissue with perfect motion stabilization.
Kevin Roggin, MD
Robotics opens new horizons
Becoming a leader in robotic total gastrectomies was not something Dr. Roggin ever imagined would happen in his career. “During my training, technologies like laparoscopic surgery were just becoming more popular, but most cancer operations I did were still open,” he said.
Working with departmental colleagues, he did more laparoscopic work until Jeffrey B. Matthews, MD, Chair of the Department of Surgery, and Mitchell C. Posner, MD, Chief of General Surgery and Surgical Oncology, approached him in 2017 with the idea of doing robotic surgery as a way to better serve our patients.
“It was a huge undertaking,” Dr. Roggin remembered. “These were complex operations utilizing a technique that was new to me. But I did the same thing I tell my residents to do when I teach: I read everything I could and spent 100+ hours in our lab on the console, perfecting my technique.” He even practiced robotic suturing on his children’s dolls, after using up castaway tubes from the simulation lab.
Pushing the boundaries
“It has been really refreshing to learn something new,” said Dr. Roggin. “When I was training, I wanted to use my hands and my mind to help people and affect their lives in a positive way. I expected to be doing these big, open, hard cases. It was not until I saw colleagues around the country performing robotic surgeries that I realized this could be me,” he said.
“Even now, I am constantly watching my own and other robotic videos, talking to colleagues and continually learning more,” he said. “It has almost been like a second career—I never expected to have that. I am thankful that I work for leaders who encouraged me, supported me and made sure I was trained the right way.
“Our department could remain at status quo and lean on our reputation, but our leadership encourages us to push the boundaries in a way that minimizes the risk to our patients. Even though I was taking time away from clinical productivity and teaching to learn robotics, they supported me in learning this because it was important for our patients long-term,” said Dr. Roggin.
Kevin Roggin, MD
Professor of Surgery
But can you eat?
One question remains: Can you live without your stomach? While it may seem impossible to the uninitiated, you certainly can, according to Dr. Roggin. “You can still get the proper nutrients to grow and thrive; you just have to change the way that you eat.” Instead of three large meals a day, recovering patients eat eight to ten smaller meals more frequently and keep track of their diet so they learn what works for them. This is not just living, but thriving, cancer-free.
After learning he was at high risk for stomach cancer, Jon Grossman turned to experts from the UChicago Medicine Gastrointestinal Cancer Risk and Prevention program for comprehensive care.
Professor of Surgery
John C. Alverdy, MD, Sara and Harold Lincoln Thompson Professor of Surgery; Executive Vice Chair, Department of Surgery
Peter Angelos, MD, PhD, Linda Kohler Anderson Professor of Surgery; Chief, Endocrine Surgery; Associate Director, MacLean Center for Clinical Medical Ethics
Nora Jaskowiak, MD, Professor of Surgery; Surgical Director, Breast Center
Edwin L. Kaplan, MD, Professor of Surgery
Jeffrey B. Matthews, MD, Dallas B. Phemister Professor of Surgery; Chair, Department of Surgery; Surgeon-in-Chief, The University of Chicago Medicine
Mitchell C. Posner, MD, Thomas D. Jones Professor of Surgery; Chief, Section of General Surgery; Chief, Surgical Oncology; Physician-in-Chief, Comprehensive Cancer Center
Vivek N. Prachand, MD, Professor of Surgery; Chief Quality Officer, Department of Surgery; Executive Medical Director, Procedural Quality and Safety; Director, Minimally Invasive Surgery; Committee on Molecular Metabolism and Nutrition
Kevin Roggin, MD, Professor of Surgery; Program Director, General Surgery Residency Program; Associate Program Director, Complex General Surgical Oncology Fellowship
Associate Professor of Surgery
Mustafa Hussain, MD, Associate Professor of Surgery; Director, Center for the Surgical Treatment of Obesity; Associate Program Director, General Surgery
Kiran K. Turaga, MD, MPH, Associate Professor of Surgery and Obstetrics and Gynecology; Vice Chief, Section of General Surgery and Surgical Oncology (Strategy and Finance); Director, Surgical GI Cancer Program; Director, Regional Therapeutics Program
Assistant Professor of Surgery
Oliver Eng, MD, Assistant Professor of Surgery; Associate Program Director, Complex General Surgical Oncology Fellowship
Xavier M. Keutgen, MD, Assistant Professor of Surgery
Jennifer Tseng, MD, Assistant Professor of Surgery
Yalini Vigneswaran, MD, MS, Assistant Professor of Surgery
Clinical Associate Professor of Surgery
Patricia L. Turner, MD, Clinical Associate Professor of Surgery
Research Professor of Surgery
Olga Y. Zaborina, PhD, Research Professor of Surgery
John C. Alverdy, MD, was chosen to receive awards at the American Society of Colon and Rectal Surgeons Presidential Luncheon.
Peter Angelos, MD, PhD, was appointed Vice Chair for Ethics, Professional Development and Wellness of the Department of Surgery. He was selected as a Member of the American College of Surgeons Academy of Master Surgeon Educators.
Peter Angelos, MD, PhD, Jeffrey B. Matthews, MD, and Mitchell C. Posner, MD, were named 2020 Top Doctors by Chicago magazine.
Oliver Eng, MD, received an ACPMP (Appendix Cancer/Pseudomyxoma Peritonei) Research Foundation grant.
Mustafa Hussain, MD, was named a Fellow of the University of Chicago Pritzker School of Medicine Academy of Distinguished Medical Educators.
Edwin L. Kaplan, MD, received the Albert Nelson Marquis Lifetime Achievement Award.
Xavier M. Keutgen, MD, received a $100,000 grant for radiomics in thyroid nodules from the University of Chicago Center for Data and Computing.
Jeffrey B. Matthews, MD, was selected as a Member of the American College of Surgeons Academy of Master Surgeon Educators.
Mitchell C. Posner, MD, was designated an Honorary Member by the Advisory Council of the Colombian Association of Surgery.
Jennifer Tseng, MD, was appointed an Editorial Board Member for General Surgery, Surgical Council on Resident Education (SCORE), American Board of Surgery; Social Media Editor, Journal of Surgical Education; and a Training Committee member, Society of Surgical Oncology.
Al-Refaie WB, Decker PA, Ballman KV, Pisters PWT, Posner MC, Hunt KK, Meyers B, Weinberg AD, Nelson H, Newman L, Tan A, Le-Rademacher JG, Hurria A, Jatoi A. Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Annals of Surgical Oncology. 26(13): 4213-4221, 2019. PMID: 31605327.
Angelos P. Informed consent requires that the patient have the opportunity to be informed. Ann Thorac Surg. 2019 Dec;108(6):1611-1612. doi: 10.1016/j.athoracsur.2019.08.010. No abstract available. PMID: 31761258.
Angelos P. Interventions to improve consent: Perhaps surgeons should speak less and listen more. JAMA Surg. 2019 Oct 30. doi: 10.1001/jamasurg.2019.3796. [Epub ahead of print] No abstract available. PMID: 31664425.
Angelos P, O’Connor M. Responsibilities and expectations: Considerations of disclosure of overlapping operations. Ann Surg. 2020 Jan 16. doi: 10.1097/SLA.0000000000003756. [Epub ahead of print]. PMID: 31972654.
Angelos P. The value of speaking up. Narr Inq Bioethics. 2019; 9(3):229-231. doi: 10.1353/nib.2019.0069. PMID: 31956127.
Babazadeh NT, Schlund DJ, Tierney JF, Chen M, Cornelius T, Singh JS, Keutgen XM. Should 68Ga-DOTATATE PET CT be performed routinely in patients with neuroendocrine tumors before surgical resection? World J Surg. 2019 Oct 1.
Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, Levine E, Maker A, Mamounas E, McGuire K, Merchant N, Shibata D, Sohn V, Solorzano C, Turaga KK, White R, Yang A, Yoon S; Society of Surgical Oncology. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann Surg Oncol 2020 Apr 8, doi: 10.1245/s10434-020-08461-2.
Bedi M, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Cardona K, King DM. (2020). Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? Clinical Orthopaedics and Related Research, 478(3), 550–559. doi: 10.1097/CORR.0000000000000959.
Blakely AM, Chanson D, Wong FL, Eng OS, Sentovich SM, Melstrom KM, Lai LL, Fong Y, Sun V. Health-Related Quality of Life and Oncologic Outcomes after Surgery in Older Adults with Colorectal Cancer. Supportive Care in Cancer. 2020 Jun;28(6):2857-2865. Epub 2019 Nov 15.
Blakely AM, Lafaro KJ, Eng OS, Ituarte PH, Fakih M, Lee B, Raoof M. The Association of Tumor Laterality and Survival after Cytoreduction for Colorectal Carcinomatosis. Journal of Surgical Research. 2020 Apr;248:20-27. Epub 2019 Dec 13.
Bryan AF, Bryan DS, Matthews JB, Roggin KK. (2020). Toward Autonomy and Conditional Independence: A Standardized Script Improves Patient Acceptance of Surgical Trainee Roles. Journal of Surgical Education, 77(3), 534–539. doi: 10.1016/j.jsurg.2020.01.015.
Bryan AF, Milner R, Roggin KK, Angelos P, Matthews JB. (2020). Unknown Unknowns: Surgical Consent during the COVID-19 Pandemic. Annals of Surgery, 10.1097/SLA.0000000000003995. Advance online publication. doi: 10.1097/SLA.0000000000003995.
Bryan DS, Benjamin AJ, Schneider AB, Milner R, Matthews JB, Roggin KK. (2020). Nimble, Together: A Training Program’s Response to the COVID-19 Pandemic. Annals of Surgery, 10.1097/SLA.0000000000003994. Advance online publication. doi: 10.1097/SLA.0000000000003994.
Catenacci D, Chase L, Lomnicki S, Karrison T, de Wilton Marsh R, Rampurwala MM, Narula S, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Peterson B, Moore K, Kipping-Johnson K, Markevicius U, Gordon B, Allen K, Racette C, Maron SB, Posner MC. (2020). Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Network Open, 3(2), e1921290. doi: 10.1001/jamanetworkopen.2019.21290.
Catenacci DVT, Chase L, Lomnicki S, Karrison T, de Wilton Marsh R, Rampurwala MM, Narula S, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Peterson B, Moore K, Kipping-Johnson K, Markevicius U, Gordon B, Allen K, Racette C, Maron SB, Liao CY, Polite BN, Kindler HL, Turaga K, Prachand VN, Roggin KK, Ferguson MK, Posner MC. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 Feb 5;3(2):e1921290. doi: 10.1001/jamanetworkopen.2019.21290.
Chien AJ, et al and I-SPY2 Investigators, 2020. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY2 Trial. J Clin Onc; 38(10):1059-1069. PMID: 32031889.
Chivukula SV, Tierney J, Hertl M, Poirier J, Keutgen XM; Surgical resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients? Surgery. 2019 Sep 16. pii: S0039-6060(19)30469-6.
Choudry MH, Bartlett DL, Alexander HR, Turaga KK. Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies. Ann Surg Oncol. 2020 Jan;27(1):73-75. doi: 10.1245/s10434-019-07956-x.
Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D’Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI. (2019). Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of Surgical Oncology, 120(7), 1227–1234. doi: 10.1002/jso.25694.
Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos K. (2019). Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of Surgical Oncology, 120(3), 340–347. doi: 10.1002/jso.25606.
Cobianchi L, Pugliese L, Peloso A, Dal Mas F, Angelos P. To a new normal: Surgery and COVID-19 during the Transition Phase. Ann Surg. May 20 [Epub ahead of print] https://doi: 10.1097/SLA.0000000000004083. 2020.
Ellison EC, Ponsky JL, Harrison MR, McGrath MH, Angelos P, Krummel TM. Presidential Forum. Ann Surg. 2019 Oct; 270(4):573-584. doi: 10.1097/SLA.0000000000003421. PMID: 31274654.
Eng OS, Pawlik TM, Ejaz A. Cancer Surgery During COVID-19: How We Move Forward. Annals of Surgery. Epub 2020 May 20.
Eng OS, Tseng J, Ejaz A, Pawlik TM, Angelos P. Apples to Oranges: Ethical Considerations in COVID-19 Recovery. Annals of Surgery. Epub 2020 May 20.
Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, Howard JH, Gamblin TC, Roggin KK, Votanopoulos K, Fields RC, Maithel SK, Delman KA, Cardona K. (2019). Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan? Journal of the American College of Surgeons, 229(5), 449–457. doi: 10.1016/j.jamcollsurg.2019.07.010.
Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M. (2019). The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. Journal of Surgical Oncology, 120(3), 325–331. doi: 10.1002/jso.25522.
Guindalini RSC, et al, 2019. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical Cancer Research 25(6): 1786-1794. PMID: 30154229.
Haisley KR, DeSouza ML, Dewey EN, et al. Assessment of Routine Esophagram for Detecting Anastomotic Leak After Esophagectomy. JAMA Surg. 2019; 154(9):879-881. doi:10.1001/jamasurg.2019.2162.
Howe JR, Merchnt NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, et al. NANETS Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors, Pancreas. 2020 Jan;49(1):1-33.
Hussain MI, Nelson AM, Yeung BG, Sukumar L, Zheng K. (2020). How the presentation of patient information and decision-support advisories influences opioid prescribing behavior: A simulation study. Journal of the American Medical Informatics Association: JAMIA, 27(4), 613–620. doi: 10.1093/jamia/ocz213.
Hussain MI, Reynolds TL, Zheng K. (2019). Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: a systematic review. Journal of the American Medical Informatics Association: JAMIA, 26(10), 1141–1149. doi: 10.1093/jamia/ocz095.
Kantor O, Bao J, Jaskowiak N, Yao K, Tseng J. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Onc. 2020 Feb;27(2):352-358. PMID: 31376037.
Lee RM, Ethun CG, Zaidi MY, Tran TB, Grignol V, Howard JH, Bedi M, Gamblin T, Tseng J, Roggin KK, Chouliaras K, Votanopoulos KI, Krasnick BA, Fields RC, Oskouei S, Monson D, Reimer NB, Maithel S, Cardona K. A Closer Look at the Natural History and Recurrence Patterns of High-Grade Truncal/Extremity Leiomyosarcomas: An Analysis from the U.S. Sarcoma Collaborative. Accepted for publication in Surgical Oncology.
Levinsky NC, Morris MC, Wilma K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. Journal of Gastrointestinal Surgery. 2020 Jan;24(1):155-164. Epub 2019 Aug 19.
McGee MF, Kreutzer L, Quinn CM, Yang A, Shan Y, Halverson AL, Love R, Johnson JK, Memeh K, Ruhle B, Vaghaiwalla T, Kaplan E, Keutgen X, Angelos P. Thyroidectomy for euthyroid patients with Hashimoto thyroiditis and persisting symptoms: A cost-effectiveness analysis. Surgery. 2020 May 24:S0039-6060(20)30172-0.
Memeh K, Ruhle B, Vaghaiwalla T, Kaplan E, Keutgen X, Angelos P. Thyroidectomy for euthyroid patients with Hashimoto thyroiditis and persisting symptoms: A cost-effectiveness analysis. Surgery. 2020 May 24:S0039-6060(20)30172-0.
Nanda R, et al and I-SPY2 Investigators, 2020. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 6(5): 1-9. PMID: 32053137.
Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE. Executive summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Management of Thyroid Disease in Adults. Ann Surg. 2020 Mar;271(3):399-410. doi: 10.1097/SLA.0000000000003735. PMID: 32079828.
Plana AG, Cotter TG, Turaga KK. Gastric volvulus involving the duodenum. BMJ Case Rep. 2019 Jul 27;12(7). pii: e229930. doi: 10.1136/bcr-2019-229930.
Poli EC, Millis AM, Berger Y, Sherman SK, Schuitevoerder D, Dahdaleh F, Kamm A, Eng OS, Turaga KK. Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Journal of Surgical Oncology. 2019 Nov;120(6):1044-1045. Epub 2019 Aug 19.
Prachand V, Bilimoria KY, Illinois Surgical Quality Improvement Collaborative (ISQIC) (2019). Leveraging a Comprehensive Program to Implement a Colorectal Surgical Site Infection Reduction Bundle in a Statewide Quality Improvement Collaborative. Annals of Surgery, 270(4), 701–711. doi: 10.1097/SLA.0000000000003524.
Prachand V, Tseng J, Milner R, Posner M, Matthews J. (2020). Web-Based Medically Necessary, Time-Sensitive (MeNTS) Procedure Scoring Worksheet: In Reply to Ing and Ing. Journal of the American College of Surgeons, 231(3), 407. doi: 10.1016/j.jamcollsurg.2020.05.016.
Prachand VN, Milner R, Angelos P, Posner MC, Fung JJ, Agrawal N, Jeevanandam V, Matthews JB. (2020). Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic. Journal of the American College of Surgeons, 231(2), 281–288. doi: 10.1016/j.jamcollsurg.2020.04.011.
Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, Jakub JW. Germline Genetic Mutations in a Multi-center Contemporary Cohort of 550 Phyllodes Tumors: An Opportunity for Expanded Multi-gene Panel Testing [published online ahead of print, 2020 Jun 5]. Ann Surg Oncol. 2020; 10.1245/s10434-020-08480-z. doi:10.1245/s10434-020-08480-z. PMID: 32504368.
Sawka AM, Gagliardi AR, Haymart MR, Sturgeon C, Bernet V, Hoff KC, Angelos P, Brito JP, Haugen BR MD, Kim BW, Kopp PA, Mandel SJ, Ross DS, Samuels M, Sarne DH, Sinclair CF, Jonklaas J. A survey of American Thyroid Association members regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Guidelines. Thyroid. 2019 Dec 13. doi: 10.1089/thy.2019.0486. [Epub ahead of print] PMID: 31830853.
Schuitevoerder D, Vining CC, Tseng J. Adjuvant Therapy for Cutaneous Melanoma. Surg Oncol Clin N Am. 2020; 29(3):455-465. doi: 10.1016/j.soc.2020.02.009. PMID: 32482320.
Schwartz PB, Poultsides G, Roggin K, Howard JH, Fields RC, Clarke CN, Votanopoulos K, Cardona K, Winslow ER. (2020). PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. The Journal of Surgical Research, 251, 228–238. doi: 10.1016/j.jss.2020.01.008.
Schwartz PB, Stahl CC, Ethun C, Marka N, Poultsides GA, Roggin KK, Fields RC, Howard JH, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE. (2020). Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculator. Journal of Surgical Oncology, 10.1002/jso.26071. Advance online publication. doi: 10.1002/jso.26071.
Sell NM, Qadan M, Delman KA, Roggin KK, Spain DA, Phitayakorn R, Lillemoe KD, Mullen JT. (2020). Implications of COVID-19 on the General Surgery Match. Annals of Surgery, 10.1097/SLA.0000000000004032. Advance online publication. doi: 10.1097/SLA.0000000000004032.
Sheckter CC, Singh P, Angelos P, Offodile AC. Surprise billing in surgical care episodes—Overview, ethical concerns, and policy solutions in light of COVID-19. Ann Surg. Forthcoming 2020.
Shelby RD, Suarez-Kelly LP, Yu PY, Hughes TM, Ethun CG, Tran TB, Poultsides G, King DM, Bedi M, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Howard JH, Cardona K, Grignol V. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020 Jun;121(8):1249-1258. doi: 10.1002/jso.25905. Epub 2020 Mar 30. PMID: 32232871.
Skertich NJ, Tierney JF, Chivukula SV, Babazadeh NT, Hertl M, Poirier J, Keutgen XM. Risk factors associated with positive resection margins in patients with adrenocortical carcinoma. Am J Surg. 2020 Feb 22:S0002-9610(20)30121-5.
Slidell MB, Kandel JJ, Prachand V, Baroody FM, Gundeti MS, Reid RS, Angelos P, Matthews JB, Mak GZ. Pediatric modification of the medically necessary, time-sensitive scoring system for operating room procedure prioritization during the COVID-19 pandemic. J Am Coll Surg. 2020 May 27 doi: 10.1016/j.jamcollsurg.2020.05.015 [Epub ahead of print] PMCID: PMC7251404.
Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH. (2020). Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. The Journal of Surgical Research, 245, 577–586. doi: 10.1016/j.jss.2019.08.002.
Strong EA, Park SH, Chow BA, Ethun CC, Hembrook MA, Bedi MA, Charlson JA, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Howard J, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin T, Cardona K, Clarke CN. High Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Extremity Soft Tissue Sarcoma. Accepted for publication in Surgery.
Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative (2020). Outcomes of palliative-intent surgery in retroperitoneal sarcoma–Results from the US Sarcoma Collaborative. Journal of Surgical Oncology, 121(7), 1140–1147. doi: 10.1002/jso.25890.
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar I, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Shmulevich I. (2019). The Immune Landscape of Cancer. Immunity, 51(2), 411–412. doi: 10.1016/j.immuni.2019.08.004.
Tierney J, Chivukula SV, Schadde E, Pappas SG, Poirier J, Kebebew E, Keutgen XM. Update in National Treatment Practices of Adrenocortical Cancer in the United States: Have We Made Any Progress? J Clin Endocrinol Metab. 2019 Jul 30. pii: jc.2019-00915.
Tierney J, Vogl A, Chivukula SV, Min IM, Scognamiglio T, Gattuso P, Pappas SG, Fahey TJ, Keutgen XM. Indoleamine-2, 3-dioxygenase 1 (IDO-1) as a potential novel target for adrenocortical carcinoma; J Surg Res. 2020 Jul 16;256:90-95.
Tran DK, Angelos P. How should shared decision making be taught? AMA J Ethics. 220: 22(5): E388-394.
Tran L, Nhu Y M, Le Ba Nghia T, Hendam A, Vuong NL, Alzalal E, Sayed AM, Hussain MM, Sharma A, Tieu T, Mathenge PG, Hirayama K, Alexander N, Huy NT. (2020). Frequent inappropriate use of unweighted summary statistics in systematic reviews of pathogen genotypes or genogroups. Journal of Clinical Epidemiology, 119, 26–35. doi: 10.1016/j.jclinepi.2019.11.009.
Tseng J. How Has COVID-19 Affected the Costs of the Surgical Fellowship Interview Process? [published online ahead of print, 2020 May 20]. J Surg Educ. 2020;S1931-7204(20)30153-7. doi:10.1016/j.jsurg.2020.05.018. PMID: 32507697.
Tseng J. Learning theories and principles in surgical education and technical learning. J Surg Oncol. 2020; 122(1):11-14. doi:10.1002/jso.25936. PMID: 32441357.
Tseng J, Posner MC. For Gastroesophageal Junction Cancers, Does an “Esophageal” or “Gastric” Surgical Approach Offer Better Perioperative and Oncologic Outcomes? Annals of Surgical Oncology. 27(2):511-517, 2020. PMID: 31571057.
Tseng J, Roggin KK, Angelos P. (2020). Should This Operation Proceed? When Residents and Faculty Disagree During the COVID-19 Pandemic and Recovery. Annals of Surgery, 10.1097/SLA.0000000000004080. Advance online publication. doi: 10.1097/SLA.0000000000004080.
Tun S, Eng OS, Malec M. Editorial: “Health-Related Quality of Life after Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.” Annals of Surgical Oncology. 2020 Mar;27(3):630-631. Epub 2019 Dec 17. (Invited Editorial)
Turaga KK, Girotra S. Are we harming patients by delaying cancer surgery during the COVID-19 epidemic? Ann Surg 2020 Apr, Epub.
Turner M, Vigneswaran Y, Dewey E, et al. Weight loss and co-morbidity resolution between different races and ethnicities after gastric bypass. Surg Obes Relat Dis. 2019; 15(11):1943-1948. doi:10.1016/j.soard.2019.09.061.
Uppal A, Smieliauskas F, Sharma MR, Maron SB, Polite BN, Posner MC, Turaga K. Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer: 125(2):282-292, 2020. PMID: 31639217.
Vaghaiwalla T, Keutgen XM. Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020 Apr;29(2):243-252.
Vaghaiwalla T, Ruhle B, Memeh K, Angelos P, Kaplan E, Liao CY, Polite B, Keutgen XM. Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2020 May 20:S0039-6060(20)30178-1.
Vigneswaran Y, Prachand VN, Posner MC, Matthews JB, Hussain M. What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate? J Gastrointest Surg. 2020; 24(7):1686-1691. doi:10.1007/s11605-020-04592-9.
Vining CC, Izquierdo F, Eng OS, Turaga KK. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Technical Considerations and the Learning Curve. Journal of Surgical Oncology. Epub 2020 May 20. (Invited Review).
Vining CC, Eng OS, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ, Roggin KK, Talamonti MS, Posner MC, Turaga KK, Tseng J. (2020). Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Annals of Surgical Oncology, 1–5. Advance online publication. doi: 10.1245/s10434-020-08623-2.
Vining CC, Kuchta K, Schuitevoerder D, Paterakos P, Berger Y, Roggin KK, Talamonti MS, Hogg ME. (2020). Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. Journal of Surgical Oncology, 122(2), 183–194. doi: 10.1002/jso.25942.
Volodarskaya M, Tucker AB, Tseng J. Medical Student Research in Surgery: From Abstract Presentation to Publication [published online ahead of print, 2020 Jun 12]. J Surg Educ. 2020; S1931-7204(20)30146-X. doi:10.1016/j.jsurg.2020.05.011. PMID: 32540121.
Wang J, Eng OS, Micic D. Getting to the Root of the Problem. Gastroenterology. 2020 Apr;158(5):1229-1231. Epub 2019 Sep 24.
Wei AC, Ou FS, Shi Q, Carrero X, O’Reilly EM, Meyerhardt J, Wolff RA, Kindler HL, Evans DB, Deshpande V, Misdraji J, Tamm E, Sahani D, Moore M, Newman E, Merchant N, Berlin J, Goff LW, Pisters P, Posner MC. Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Annals of Surgical Oncology. 26(13): 44489-4497, 2019. PMID: 31418130.
Wiseman JT, Ethun CG, Cloyd JM, Shelby R, Suarez-Kelly L, Tran T, Poultsides G, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields R, Walle KV, Ronnekleiv-Kelly S, Howard JH, Cardona K, Grignol V. (2020). Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. Journal of Surgical Oncology, 10.1002/jso.26136. Advance online publication. doi: 10.1002/jso.26136.
Xue L, Hyman NH, Turaga KK, Eng OS. Peritoneal Metastases in Colorectal Cancer: Biology and Barriers. Journal of Gastrointestinal Surgery. Epub 2019 Nov 19. (Invited Review).
Yang AD, Hewitt DB, Blay E Jr, Kreutzer LJ, Quinn CM, Cradock KA, Prachand V, Bilimoria KY, Illinois Surgical Quality Improvement Collaborative (ISQIC) (2020). Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis. Annals of Surgery, 271(6), 1072–1079. doi: 10.1097/SLA.0000000000003124.
Zaidi MY, Ethun CG, Liu Y, Poultsides G, Howard JH, Mogal H, Tseng J, Votanopoulos K, Fields RC, Cardona K. The Impact of Unplanned Excisions of Soft Tissue Sarcomas: A Multi-Institutional Propensity Score Analysis from the US-Sarcoma Collaborative. J Surg Oncol. 2019 Sept;120(3):332-339.
Zaidi MY, Ethun CG, Tran TB, Poultsides G, Grignol VP, Howard JH, Bedi M, Mogal H, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields RC, Oskouei S, Reimer N, Monson D, Maithel SK, Cardona K. (2019). Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Annals of Surgical Oncology, 26(11), 3542–3549. doi: 10.1245/s10434-019-07639-7.
residents & fellows
View the General Surgery Residents and Fellows here.